Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI
NCT03967080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2025-09-03
Summary
This small study will investigate the feasibility of using multi-parametric MRI to introduce and support adaptive radiotherapy treatments for high-risk prostate cancer.
Conditions
Sponsors & Collaborators
-
East and North Hertfordshire NHS Trust
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-05
- Primary Completion
- 2024-09-01
- Completion
- 2024-09-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors
NCT04704804 ·Status: COMPLETED
-
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer
NCT02107287 ·Status: COMPLETED ·Phase: NA
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07325721 ·Status: RECRUITING ·Phase: PHASE2
-
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
NCT02470910 ·Status: COMPLETED ·Phase: NA
-
Tumor TARGET Prostate Cancer
NCT01802242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate
NCT00548600 ·Status: COMPLETED ·Phase: PHASE3
-
MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy
NCT00775866 ·Status: COMPLETED ·Phase: NA
-
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
NCT04612907 ·Status: RECRUITING ·Phase: NA
-
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer
NCT03561220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial
NCT07300566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
NCT02935816 ·Status: UNKNOWN
-
Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer
NCT07152067 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy
NCT02721784 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
NCT03933670 ·Status: RECRUITING ·Phase: PHASE2
-
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
NCT05183074 ·Status: RECRUITING ·Phase: NA
-
A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer
NCT05430737 ·Status: UNKNOWN ·Phase: NA
-
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
NCT05361902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MRI Guided SBRT for Localized Prostate Cancer
NCT03778112 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostate Cancer Screening Trial Using Imaging
NCT03702439 ·Status: COMPLETED
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fiducial Localization and Individualized Radiotherapy -Prostate Cancer
NCT00789607 ·Status: COMPLETED ·Phase: NA
-
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion
NCT01913717 ·Status: UNKNOWN ·Phase: NA
-
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NCT03160794 ·Status: RECRUITING ·Phase: NA
-
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer
NCT05313815 ·Status: RECRUITING ·Phase: NA